DSG3 as a biomarker for the ultrasensitive detection of occult lymph node metastasis in oral cancer using nanostructured immunoarrays

Oral Oncology

Volumn 49, Issue 2, 2013, Pages 93-101

  Patel, Vyomesh ^a   Martin, Daniel ^a   Malhotra, Ruchika ^b   Marsh, Christina A ^a   Doçi, Colleen L ^a   Veenstra, Timothy D ^f   Nathan, Cherie Ann O ^c   Sinha, Uttam K ^d   Singh, Bhuvanesh ^e   Molinolo, Alfredo A ^a   Rusling, James F ^b   Gutkind, J Silvio ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^f SAIC FREDERICK INC   (United States)

Author keywords

Biomarker; Desmosomes; DSG3; Head and neck cancer; Immunoarray; Lymph nodes metastasis; Nanosensors; Proteomics; SCC; Sentinel lymph nodes

Indexed keywords

BIOLOGICAL MARKER; DESMOGLEIN 3;

ARTICLE; CERVICAL LYMPH NODE; CONTROLLED STUDY; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MICROFLUIDIC ANALYSIS; MORBIDITY; POINT OF CARE TESTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE MICROARRAY;

BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; DESMOGLEIN 3; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MICROFLUIDICS; MOUTH NEOPLASMS; NANOSTRUCTURES; SENSITIVITY AND SPECIFICITY; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84872323190     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2012.08.001     Document Type: Article

References (41)

1. J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers, and D.M. Parkin Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int J Cancer 127 12 2010 2893 2917
2. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 CA Cancer J Clin 62 1 2012 10 29
3. A. Forastiere, W. Koch, A. Trotti, and D. Sidransky Head and neck cancer N Engl J Med 345 26 2001 1890 1900
4. J.R. Clark, N. Naranjo, J.H. Franklin, J. de Almeida, and P.J. Gullane Established prognostic variables in N0 oral carcinoma Otolaryngol Head Neck Surg 135 5 2006 748 753
5. M.A. Kuriakose, and N.P. Trivedi Sentinel node biopsy in head and neck squamous cell carcinoma Curr Opin Otolaryngol Head Neck Surg 17 2 2009 100 110
6. C.R. Leemans, R. Tiwari, J.J. Nauta, I. van der Waal, and G.B. Snow Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor Cancer 73 1 1994 187 190
7. J.P. Shah, F.C. Candela, and A.K. Poddar The patterns of cervical lymph node metastases from squamous carcinoma of the oral cavity Cancer 66 1 1990 109 113
8. E.E. Vokes, R.R. Weichselbaum, S.M. Lippman, and W.K. Hong Head and neck cancer N Engl J Med 328 3 1993 184 194
9. G.B. Snow, A.A. Annyas, E.A. van Slooten, H. Bartelink, and A.A. Hart Prognostic factors of neck node metastasis Clin Otolaryngol Allied Sci 7 3 1982 185 192
10. G. Mamelle, J. Pampurik, B. Luboinski, R. Lancar, A. Lusinchi, and J. Bosq Lymph node prognostic factors in head and neck squamous cell carcinomas Am J Surg 168 5 1994 494 498
11. M.H. Weiss, L.B. Harrison, and R.S. Isaacs Use of decision analysis in planning a management strategy for the stage N0 neck Arch Otolaryngol Head Neck Surg 120 7 1994 699 702
12. V. Bar Ad, and A. Chalian Management of clinically negative neck for the patients with head and neck squamous cell carcinomas in the modern era Oral Oncol 44 9 2008 817 822
13. M. Cianchetti, A.A. Mancuso, R.J. Amdur, J.W. Werning, J. Kirwan, and C.G. Morris Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site Laryngoscope 119 12 2009 2348 2354
14. M.W. van den Brekel, J.A. Castelijns, H.V. Stel, R.P. Golding, C.J. Meyer, and G.B. Snow Modern imaging techniques and ultrasound-guided aspiration cytology for the assessment of neck node metastases: a prospective comparative study Eur Arch Otorhinolaryngol 250 1 1993 11 17
15. E.G. Troost, W.V. Vogel, M.A. Merkx, P.J. Slootweg, H.A. Marres, and W.J. Peeters 18F-FLT PET does not discriminate between reactive and metastatic lymph nodes in primary head and neck cancer patients J Nucl Med 48 5 2007 726 735
16. E. Ozer, B. Naiboglu, R. Meacham, C. Ryoo, A. Agrawal, and D.E. Schuller The value of PET/CT to assess clinically negative necks Eur Arch Otorhinolaryngol 2012
17. Y. Yamazaki, M. Saitoh, K. Notani, K. Tei, Y. Totsuka, and S. Takinami Assessment of cervical lymph node metastases using FDG-PET in patients with head and neck cancer Ann Nucl Med 22 3 2008 177 184
18. H. Schoder, D.L. Carlson, D.H. Kraus, H.E. Stambuk, M. Gonen, and Y.E. Erdi 18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI J Nucl Med 47 5 2006 755 762
19. G.Q. Phan, J.L. Messina, V.K. Sondak, and J.S. Zager Sentinel lymph node biopsy for melanoma: indications and rationale Cancer Control 16 3 2009 234 239
20. M. Salhab, N. Patani, and K. Mokbel Sentinel lymph node micrometastasis in human breast cancer: an update Surg Oncol 20 4 2011 e195 e206
21. V. Patel, B.L. Hood, A.A. Molinolo, N.H. Lee, T.P. Conrads, and J.C. Braisted Proteomic analysis of laser-captured paraffin-embedded tissues: a molecular portrait of head and neck cancer progression Clin Cancer Res 14 4 2008 1002 1014
22. M. Amagai, and J.R. Stanley Desmoglein as a target in skin disease and beyond J Invest Dermatol 132 3 Pt 2 2012 776 784
23. J.F. Rusling, C.V. Kumar, J.S. Gutkind, and V. Patel Measurement of biomarker proteins for point-of-care early detection and monitoring of cancer Analyst 135 10 2010 2496 2511
24. B.S. Munge, A.L. Coffey, J.M. Doucette, B.K. Somba, R. Malhotra, and V. Patel Nanostructured immunosensor for attomolar detection of cancer biomarker interleukin-8 using massively labeled superparamagnetic particles Angew Chem Int Ed Engl 50 34 2011 7915 7918
25. R. Malhotra, V. Patel, J.P. Vaque, J.S. Gutkind, and J.F. Rusling Ultrasensitive electrochemical immunosensor for oral cancer biomarker IL-6 using carbon nanotube forest electrodes and multilabel amplification Anal Chem 82 8 2010 3118 3123
26. B.V. Chikkaveeraiah, V. Mani, V. Patel, J.S. Gutkind, and J.F. Rusling Microfluidic electrochemical immunoarray for ultrasensitive detection of two cancer biomarker proteins in serum Biosens Bioelectron 26 11 2011 4477 4483
27. B.V. Chikkaveeraiah, A. Bhirde, R. Malhotra, V. Patel, J.S. Gutkind, and J.F. Rusling Single-wall carbon nanotube forest arrays for immunoelectrochemical measurement of four protein biomarkers for prostate cancer Anal Chem 81 21 2009 9129 9134
28. G.A. Jeon, J.S. Lee, V. Patel, J.S. Gutkind, S.S. Thorgeirsson, and E.C. Kim Global gene expression profiles of human head and neck squamous carcinoma cell lines Int J Cancer 112 2 2004 249 258
29. A.A. Molinolo, S.M. Hewitt, P. Amornphimoltham, S. Keelawat, S. Rangdaeng, and A. Meneses Garcia Dissecting the Akt/mammalian target of rapamycin signaling network: emerging results from the head and neck cancer tissue array initiative Clin Cancer Res 13 17 2007 4964 4973
30. M.A. Broglie, S.R. Haile, and S.J. Stoeckli Long-term experience in sentinel node biopsy for early oral and oropharyngeal squamous cell carcinoma Ann Surg Oncol 18 10 2011 2732 2738
31. S.P. Leong, M. Zuber, R.L. Ferris, Y. Kitagawa, R. Cabanas, and C. Levenback Impact of nodal status and tumor burden in sentinel lymph nodes on the clinical outcomes of cancer patients J Surg Oncol 103 6 2011 518 530
32. M.N. Elsheikh, A. Rinaldo, H. Hamakawa, M.E. Mahfouz, J.P. Rodrigo, and J. Brennan Importance of molecular analysis in detecting cervical lymph node metastasis in head and neck squamous cell carcinoma Head Neck 28 9 2006 842 849
33. M.T. Becker, C.G. Shores, K.K. Yu, and W.G. Yarbrough Molecular assay to detect metastatic head and neck squamous cell carcinoma Arch Otolaryngol Head Neck Surg 130 1 2004 21 27
34. R. Garrel, M. Dromard, V. Costes, E. Barbotte, F. Comte, and Q. Gardiner The diagnostic accuracy of reverse transcription-PCR quantification of cytokeratin mRNA in the detection of sentinel lymph node invasion in oral and oropharyngeal squamous cell carcinoma: a comparison with immunohistochemistry Clin Cancer Res 12 8 2006 2498 2505
35. T.Y. Seiwert, R. Jagadeeswaran, L. Faoro, V. Janamanchi, V. Nallasura, and M. El Dinali The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma Cancer Res 69 7 2009 3021 3031
36. R. Szabo, A.L. Rasmussen, A.B. Moyer, P. Kosa, J.M. Schafer, and A.A. Molinolo C-Met-induced epithelial carcinogenesis is initiated by the serine protease matriptase Oncogene 30 17 2011 2003 2016
37. G. Cortesina, T. Martone, E. Galeazzi, M. Olivero, A. De Stefani, and M. Bussi Staging of head and neck squamous cell carcinoma using the MET oncogene product as marker of tumor cells in lymph node metastases Int J Cancer 89 3 2000 286 292
38. R.L. Ferris, L. Xi, S. Raja, J.L. Hunt, J. Wang, and W.E. Gooding Molecular staging of cervical lymph nodes in squamous cell carcinoma of the head and neck Cancer Res 65 6 2005 2147 2156
39. R.L. Ferris, L. Xi, R.R. Seethala, J. Chan, S. Desai, and B. Hoch Intraoperative qRT-PCR for detection of lymph node metastasis in head and neck cancer Clin Cancer Res 17 7 2011 1858 1866
40. J. Solassol, V. Burcia, V. Costes, J. Lacombe, A. Mange, and E. Barbotte Pemphigus vulgaris antigen mRNA quantification for the staging of sentinel lymph nodes in head and neck cancer Br J Cancer 102 1 2010 181 187
41. L. Wang, T. Liu, Y. Wang, L. Cao, M. Nishioka, and R.L. Aguirre Altered expression of desmocollin 3, desmoglein 3, and beta-catenin in oral squamous cell carcinoma: correlation with lymph node metastasis and cell proliferation Virchows Archiv: Int J Pathol 451 5 2007 959 966